Vitamin B6 activates p53 and elevates p21 gene expression in cancer cells and the mouse colon

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2371-2376

  Zhang, Peipei ^a   Suidasari, Sofya ^a   Hasegawa, Tomomi ^a   Yanaka, Noriyuki ^a   Kato, Norihisa ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Colon cancer cells; Mouse; P21; P53; Pyridoxal

Indexed keywords

MESSENGER RNA; PROTEIN P21; PROTEIN P53; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; PYRIDOXINE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PYRIDOXAL;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CACO 2 CELL LINE; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; DIET; DRUG EFFECTS; ENZYME ACTIVATION; GENETICS; HEK293 CELL LINE; HEPG2 CELL LINE; HT 29 CELL LINE; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER NEOPLASMS;

ANIMALS; CACO-2 CELLS; CARCINOMA, HEPATOCELLULAR; COLORECTAL NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DIET; ENZYME ACTIVATION; HEK293 CELLS; HEP G2 CELLS; HT29 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED ICR; PYRIDOXAL; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84898646357     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3073     Document Type: Article

References (31)

1. Komatsu SI, Watanabe H, Oka T, Tsuge H, Nii H and Kato N: Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131: 2204-2207, 2001
2. Komatsu S, Watanabe H, Oka T, Tsuge H and Kato N: Dietary vitamin B6 suppresses colon tumorigenesis, 8-hydroxyguanosine, 4-hydroxynonenal, and inducible nitric oxide synthase protein in azoxymethane-treated mice. J Nutr Sci Vitaminol 48: 65-68, 2002
3. Ishihara J, Otani T, Inoue M, Iwasaki M, Sasazuki S, Tsugane S and Japan Public Health Center-based Prospective Study Group: Low intake of vitamin B-6 is associated with increased risk of colorectal cancer in Japanese men. J Nutr 137: 1808-1814, 2007
4. Theodoratou E, Farrington SM, Tenesa A, et al: Dietary vitamin B6 intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 17: 171-182, 2008
5. Larsson SC, Orsini N and Wolk A: Vitamin B6 and risk of colorectal cancer: A meta-analysis of prospective studies. JAMA 303: 1077-1083, 2010
6. Zhang XH, Ma J, Smith-Warner SA, Lee JE and Giovannucci E: Vitamin B6 and colorectal cancer: Current evidence and future directions. World J Gastroenterol 19: 1005-1010, 2013
7. Yanaka N, Koyama TA, Komatsu S, Nakamura E, Kanda M and Kato N: Vitamin B6 suppresses NF-?B activation in LPS-stimulated mouse macrophages. Int J Mol Med 16: 1071-1075, 2005
8. Matsubara K, Mori M, Matsuura Y and Kato N: Pyridoxal 5'-phosphate and pyridoxal inhibit angiogenesis in serum-free rat aortic ring assay. Int J Mol Med 8: 505-508, 2001
9. Komatsu S, Yanaka N, Matsubara K and Kato N: Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta 1647: 127-130, 2003
10. Kayashima T, Tanaka K, Okazaki Y, Matsubara K, Yanaka N and Kato N: Consumption of vitamin B6 reduces colonic damage and protein expression of HSP70 and HO-1, the anti-tumor targets, in rats exposed to 1,2-dimethylhydrazine. Oncol Lett 2: 1243-1246, 2011
11. Zhang PP, Suidasari S, Hasegawa T, Yanaka N and Kato N: High concentrations of pyridoxal stimulate the expression of IGFBP1 in HepG2 cells through upregulation of the ERK/c-Jun pathway. Mol Med Rep 8: 973-978, 2013
12. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816, 1993
13. Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993
14. Nakari M, Kanouchi H and Oka T: High dose of pyridoxine induces IGFBP-3 mRNA expression in MCF-7 cells and its induction is inhibited by the p53-specific inhibitor pifithrin-?. J Nutr Sci Vitaminol 57: 280-284, 2011
15. Masisi K, Suidasari S, Zhang P, Okazaki Y, Yanaka N and Kato N: Comparative study on the responses of concentrations of B6-vitamers in several tissues of mice to the dietary level of pyridoxine. J Nutr Sci Vitaminol 58: 446-451, 2012
16. Reeves GP, Nielsen HF and Fahey CG Jr.: AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123: 1939-1951, 1993
17. Kanouchi H, Shibuya M, Tsukamoto S, Fujimura Y, Tachibana H, Yamada K and Oka T: Comparisons of uptake and cell surface binding among pyridoxal, pyridoxine, and pyridoxamine in RAW264.7 cells. Nutrition 26: 648-652, 2010
18. Sakurai T, Asakura T, Mizuno A and Matsuda M: Absorption and metabolism of pyridoxamine in mice. I. Pyridoxal as the only form of transport in blood. J Nutr Sci Vitaminol 37: 341-348, 1991
19. Pasz-Walczak G and Kordek R: Comparative evaluation of the expression of cell cycle regulating proteins: Cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pol J Pathol 51: 63-69, 2000
20. King ML and Murphy LL: Role of cyclin inhibitor protein p21 in the inhibition of HCT116 human colon cancer cell proliferation by American ginseng (Panax quinquefolius) and its constituents. Phytomedicine 17: 261-268, 2010
21. Volakaki AA, Lafkas D, Kassi E, Schally AV, Papavassiliou AG and Kiaris H: Essential role of p21/waf1 in the mediation of the anti-proliferative effects of GHRH antagonist JMR-132. J Mol Endocrinol 41: 389-392, 2008
22. Yang WC, Mathew J, Velcich A, et al: Targeted inactivation of the p21(WAF1/cip1) gene enhances Apc-initiated tumor formation and the tumor-promoting activity of a Western-style high-risk diet by altering cell maturation in the intestinal mucosal. Cancer Res 61: 565-569, 2001
23. Poole AJ, Heap D, Carroll RE and Tyner AL: Tumor suppressor functions for the Cdk inhibitor p21 in the mouse colon. Oncogene 23: 8128-8134, 2004
24. Yang W, Velcich A, Lozonschi I, et al: Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice. Am J Pathol 166: 1239-1246, 2005
25. Zirbes TK, Baldus SE, Moenig SP, et al: Prognostic impact of p21/waf1/cip1 in colorectal cancer. Int J Cancer 89: 14-18, 2000
26. Vitiello PF, Wu YC, Staversky RJ and O'Reilly MA: P21(Cip1) protects against oxidative stress by suppressing ER-dependent activation of mitochondrial death pathways. Free Radic Biol Med 46: 33-41, 2009
27. Komarova EA, Krivokrysenko V, Wang K, et al: P53 is a suppressor of inflammatory response in mice. FASEB J 19: 1030-1032, 2005
28. Kawauchi K, Araki K, Tobiume K and Tanaka N: Loss of p53 enhances catalytic activity of IKKbeta through O-linked beta-N-acetyl glucosamine modification. Proc Natl Acad Sci USA 106: 3431-3436, 2005
29. Scatizzi JC, Mavers M, Hutcheson J, et al: The CDK domain of p21 is a suppressor of IL-1beta-mediated inflammation in activated macrophages. Eur J Immunol 39: 820-825, 2009
30. Trakala M, Arias CF, García MI, et al: Regulation of macrophage activation and septic shock susceptibility via p21(WAF1/CIP1). Eur J Immunol 39: 810-819, 2009
31. Vousden KH and Lane DP: P53 in health and disease. Nat Rev Mol Cell Biol 8: 275-283, 2007